1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Radiotherapy: Technologies and Global Markets

Radiotherapy: Technologies and Global Markets

  • February 2015
  • -
  • BCC Research
  • -
  • 130 pages

REPORT HIGHLIGHTS

The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in 2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%.

This report provides:

An overview of the global market for radiotherapy and related technologies and applications
Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019
Discussion of major factors driving the growth for nuclear medicine including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine
Detailed information conerning major challenges the market faces including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes
Analysis of the diagnostic applications for radiotherapy such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)
Comprehensive company profiles of major players in the industry.

SCOPE OF REPORT

This research report categorizes the radiation therapy market into three types of radiation therapy, which are External Beam radiation therapy, Internal Radiation therapy/Brachytherapy and Systemic Radiation therapy. External Radiotherapy is future divided into Gamma Knife, LINACS.( 3D-CRT, IMRT,IGRT), Proton Therapy System (Proton-based and Carbon-based). Internal Radiotherapy is divided into three types: Low dose Brachytherapy (Seeds: I-125, Pd-103, Applicators and Afterloaders), High dose brachytherapy (Seeds: Ir-192, Applicators and Afterloaders) and Electronic Brachytherapy. Systemic radiation therapy is bifurcated into two segments: Alpha emitter (Radium (Ra-233) and Beta emitters (Iodine (I-131), Rhenium (Re-186), Samarium (Sm-153), Yttrium-90 (Y-90), Lutetium-177 (LU-177).
Radiation therapy has also been studied based on the various applications into: External radiation therapy applications: Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer; Internal Radiation therapy applications: Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer; and Systemic Radiation therapy applications: Hyperthyroidism, Bone Metastasis, Lymphoma, Endocrine tumor. Also, the Radiation therapy market by geography: U.S., Europe, Asia, Rest of the World.

Table Of Contents

Radiotherapy: Technologies and Global Markets

Chapter- 1: INTRODUCTION - Complimentary 4

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
RESEARCH METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: EXECUTIVE SUMMARY 3

Table Summary : RADIATION THERAPY MARKET BY TYPE, THROUGH 2019
Figure Summary : RADIATION THERAPY MARKET BY REGION, THROUGH 2019

Chapter- 3: MARKET OVERVIEW 22

INTRODUCTION
INTRODUCTION TO CANCER
INTRODUCTION TO RADIATION
MECHANISM OF ACTION
RISK MANAGEMENT AND QUALITY ASSURANCE IN RADIATION THERAPY
RADIATION THERAPY MARKET SEGMENTATION
DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS
MARKET SHARE ANALYSIS
VARIOUS CANCER TREATMENTS

Chapter- 4: RADIATION THERAPY MARKET BY PRODUCTS 58

EXTERNAL BEAM RADIATION THERAPY
MECHANISM OF ACTION
BRACHYTHERAPY
THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE
Table 5 : COMPARISON OF EXTERNAL BEAM RADIATION THERAPY AND BRACHYTHERAPY

Chapter- 5: RADIATION THERAPY MARKET BY APPLICATION 15

EXTERNAL BEAM RADIATION THERAPY MARKET
INTERNAL RADIATION THERAPY MARKET BY APPLICATION
SYSTEMIC RADIATION THERAPY

Chapter- 6: RADIATION THERAPY MARKET BY GEOGRAPHY 7

UNITED STATES
EUROPE
ASIA
REST OF THE WORLD

Chapter- 7: COMPANY PROFILES 17

ACCURAY INCORPORATED
ACTINIUM PHARMACEUTICALS INC.
AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION (ANSTO)
C. R. BARD INC.
ECKERT and ZIEGLER BEBIG S.A
ELEKTA
GE HEALTHCARE
IBA MOLECULAR
NORDION INC.
NTP RADIOISOTOPES (PTY) LTD.
SIEMENS HEALTHCARE
VARIAN MEDICAL SYSTEMS

Chapter- 8: APPENDIX A LIST OF HUMAN OF CARCINOGENIC AGENTS BY TYPE OF CANCER 1

Table 88 : LIST OF CARCINOGENIC AGENTS

Chapter- 9: APPENDIX B LIST OF ACRONYMS 3

List of Tables

Summary Table : RADIATION THERAPY MARKET BY TYPE, THROUGH 2019
Table 1 : CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
Table 2 : THE IMPACT OF CANCER PROTECTIVE FACTORS AND CANCER RISK FACTORS ON VARIOUS TYPES OF CANCERS
Table 3 : STEPS INVOLVED IN RADIATION THERAPY
Table 4 : ADVANTAGES AND DISADVANTAGES OF VARIOUS CANCER TREATMENTS
Table 5 : COMPARISON OF EXTERNAL BEAM RADIATION THERAPY AND BRACHYTHERAPY
Table 6 : EXTERNAL BEAM RADIATION THERAPY MARKET BY TYPE THROUGH 2019
Table 7 : EXTERNAL BEAM RADIATION THERAPY BY REGION, THROUGH 2019
Table 8 : GAMMA KNIFE MARKET BY REGION, THROUGH 2019
Table 9 : ELECTRON EMITTING HIGH ENERGY LINEAR ACCELERATORS BY REGION, THROUGH 2019
Table 10 : LINACS MARKET BY TECHNIQUES, THROUGH 2019
Table 11 : THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY BY REGION, THROUGH 2019
Table 12 : INTENSITY-MODULATED RADIATION THERAPY MARKET BY REGION, THROUGH 2019
Table 13 : IMAGE-GUIDED RADIATION THERAPY MARKET BY REGION, THROUGH 2019
Table 14 : OTHER LINACS MARKET BY REGION, THROUGH 2019
Table 15 : COMPARISON OF PROTON BEAM THERAPY AND CARBON ION THERAPY
Table 16 : PARTICLE THERAPY SYSTEM BY TYPE, THROUGH 2019
Table 17 : PARTICLE THERAPY SYSTEM MARKET BY REGION, THROUGH 2019
Table 18 : PROTON SYSTEMS MARKET BY REGION, THROUGH 2019
Table 19 : CARBON ION THERAPY MARKET BY REGION, THROUGH 2019
Table 20 : COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
Table 21 : ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
Table 22 : VARIOUS TYPES OF BRACHYTHERAPY IMPLANTS
Table 23 : BRACHYTHERAPY TREATMENT DURATION
Table 24 : BRACHYTHERAPY TREATMENT DOSE RATE
Table 25 : BRACHYTHERAPY TREATMENT SOURCE LOADING
Table 26 : COMPARISON OF LOW DOSE AND HIGH DOSE RADIATION THERAPY
Table 27 : GLOBAL BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019
Table 28 : GLOBAL BRACHYTHERAPY MARKET BY REGION, THROUGH 2019
Table 29 : GLOBAL LDR BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019
Table 30 : GLOBAL LDR BRACHYTHERAPY MARKET BY REGION, THROUGH 2019
Table 31 : MARKET FOR LDR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019
Table 32 : GLOBAL BRACHYTHERAPY SEEDS MARKET BY TYPE, THROUGH 2019
Table 33 : GLOBAL I-125 SEEDS MARKET BY REGION, THROUGH 2019
Table 34 : GLOBAL PD-103 SEEDS MARKET BY REGION, THROUGH 2019
Table 35 : GLOBAL OTHER LDR BRACHYTHERAPY SEEDS MARKET BY REGION, THROUGH 2019
Table 36 : LDR AFTERLOADER AND APPLICATOR MARKET BY GEOGRAPHY THROUGH 2019
Table 37 : HDR BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019
Table 38 : HDR BRACHYTHERAPY MARKET BY REGION, THROUGH 2019
Table 39 : HDR SEEDS MARKET BY PRODUCT, THROUGH 2019
Table 40 : HDR SEEDS MARKET BY REGION, THROUGH 2019
Table 41 : IR-192 SEEDS MARKET BY REGION, THROUGH 2019
Table 42 : OTHER HDR SEEDS MARKET BY REGION, THROUGH 2019
Table 43 : HDR AFTERLOADER AND APPLICATOR MARKET BY REGION, THROUGH 2019
Table 44 : COMPARISON BETWEEN RADIONUCLIDES AND ELECTRONIC BRACHYTHERAPY
Table 45 : GLOBAL ELECTRONIC BRACHYTHERAPY MARKET BY GEOGRAPHY THROUGH 2019
Table 46 : ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
Table 47 : COMPARISON OF ALPHA AND BETA PARTICLES
Table 48 : MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019
Table 49 : SYSTEMIC RADIATION THERAPY BY REGION, THROUGH 2019
Table 50 : GLOBAL ALPHA EMITTER MARKET BY TYPE, THROUGH 2019
Table 51 : GLOBAL ALPHA EMITTER MARKET BY REGION, THROUGH 2019
Table 52 : EXAMPLES OF ALPHA EMITTERS
Table 53 : ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
Table 54 : GLOBAL BETA EMITTERS MARKET BY TYPE, THROUGH 2019
Table 55 : ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
Table 56 : MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019
Table 57 : GLOBAL IODINE-131 MARKET BY REGION, THROUGH 2019
Table 58 : GLOBAL RHENIUM-186 MARKET BY REGION, THROUGH 2019
Table 59 : GLOBAL SAMARIUM-153 MARKET BY REGION, THROUGH 2019
Table 60 : GLOBAL YTTRIUM-90 MARKET BY REGION, THROUGH 2019
Table 61 : GLOBAL LUTETIUM-177 MARKET BY REGION, THROUGH 2019
Table 62 : GLOBAL OTHER BETA EMITTERS MARKET BY REGION, THROUGH 2019
Table 63 : OTHER ROUTES OF ADMINISTRATION
Table 64 : PIPELINE PRODUCTS IN RADIOPHARMACEUTICALS
Table 65 : EXTERNAL BEAM RADIATION THERAPY BY APPLICATION, THROUGH 2019
Table 66 : INTERNAL BEAM RADIATION THERAPY BY APPLICATION THROUGH 2019
Table 67 : SYSTEMIC RADIATION THERAPY BY APPLICATION, THROUGH 2019
Table 68 : U.S. RADIATION THERAPY MARKET BY TYPE, THROUGH 2019
Table 69 : U.S. INSTALLED BASE AND AGE
Table 70 : NEW CANCER CASES AND ESTIMATED DEATHS IN THE YEAR 2014
Table 71 : AGING U.S. POPULATION, 2000-2050
Table 72 : EUROPEAN RADIATION THERAPY MARKET BY TYPE THROUGH 2019
Table 73 : ASIAN RADIATION THERAPY MARKET BY TYPE, THROUGH 2019
Table 74 : COMPARISON OF INDIAN AND CHINESE RADIATION THERAPY MARKETS
Table 75 : REST OF THE WORLD RADIATION THERAPY MARKET BY TYPE, THROUGH 2019
Table 76 : ACCURAY REVENUES AND RandD EXPENDITURES, 2011-2013
Table 77 : ACCURAY PRODUCTS
Table 78 : ACCURAY RECENT NEWS
Table 79 : C.R. BARD REVENUES AND RandD EXPENDITURES, 2011-2013
Table 80 : ECKERT and ZIEGLER REVENUES AND RandD EXPENDITURES, 2011-2013
Table 81 : ECKERT and ZIEGLER RECENT NEWS
Table 82 : ELEKTA REVENUES AND RandD EXPENDITURES, 2011-2013
Table 83 : ELEKTA RECENT NEWS
Table 84 : SIEMENS REVENUES AND RandD EXPENDITURES, 2011-2013
Table 85 : SIEMENS RECENT NEWS
Table 86 : VARIAN REVENUES AND RandD EXPENDITURES, 2011-2013
Table 87 : VARIAN RECENT NEWS
Table 88 : LIST OF CARCINOGENIC AGENTS

List of Figures

Summary Figure : RADIATION THERAPY MARKET BY REGION, THROUGH 2019
Figure 1 : TYPES OF RADIATION
Figure 2 : CELL GROWTH CYCLE
Figure 3 : RADIATION THERAPY MARKET SEGMENTATION
Figure 4 : DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS IN THE RADIATION THERAPY MARKET
Figure 5 : GLOBAL AGING POPULATION
Figure 6 : FACTORS RELATED TO AGING AND THE PROMOTION OF CANCER
Figure 7 : MARKET SHARE ANALYSIS OF THE RADIATION THERAPY MARKET, 2013

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: Kol Insight

September 2016 $ 8085

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy Market in Europe

  • November 2016
    19 pages
  • Therapy  

  • Europe  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Related Market Segments :

Therapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.